Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A MYC Driven and Metabolite Executed Axis Controls the Subcellular Localization and Activity of TET DNA Hydroxylases and RNA Demethylases in B Cell Lymphomas

Zhijun Qiu, PhD, An-Ping Lin, MD, Shoulei Jiang, PhD, Binu Sasi, PhD, Patricia Dahia, MD PhD, Siyuan Zheng, PhD, Ricardo Aguiar, MD PhD

Blood (2019) 134 (Supplement_1): 114.

https://doi.org/10.1182/blood-2019-123101

Published: 2019

Journal Articles

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Adolfo E Diaz, MD, Matthew James Butler, MD, Anand Karnad, MD, Ricardo Aguiar, MD PhD

Blood (2019) 134 (Supplement_1): 1592.

https://doi.org/10.1182/blood-2019-124382

Published: 2019

Journal Articles

Cyclic-AMP Is an Actionable Novel Regulator of PD-L1 Expression in Untransformed Lymphocytes and Diffuse Large B Cell Lymphomas

Binu Sasi, PhD, Zhijun Qiu, PhD, Shoulei Jiang, PhD, An-Ping Lin, MD, Ricardo Aguiar, MD PhD

Blood (2019) 134 (Supplement_1): 3962.

https://doi.org/10.1182/blood-2019-123155

Published: 2019

Journal Articles

Heightened DNA Damage Response and p53 Activation In MiR-155 Null Cells Are Context Specific and Aid Dependent

Hakim Bouamar, PhD, Long Wang, MD, Manoela Ortega, PhD, An-Ping Lin, MD, Daifeng Jiang, PhD, Ricardo Aguiar, MD, PhD

Blood (2013) 122 (21): 2279.

https://doi.org/10.1182/blood.V122.21.2279.2279

Published: 2013

Journal Articles

Microrna-155 Controls The RB/E2F Axis In Normal and Malignant B Cells Via The Non-Canonical TGFβ1-SMAD5 Signaling Module

Daifeng Jiang, PhD, Ricardo Aguiar, MD, PhD

Blood (2013) 122 (21): 241.

https://doi.org/10.1182/blood.V122.21.241.241

Published: 2013

Journal Articles

Targeting of TNFAIP3 (A20) Links MiR-125a and MiR-125b to Constitutive Activation of the NF-KB Pathway and Lymphomagenesis

Sang-Woo Kim, PhD, Kumaraguruparan Ramasamy, PhD, Hakim Bouamar, PhD, Daifeng Jiang, PhD, Ricardo Aguiar, MD, PhD

Blood (2011) 118 (21): 774.

https://doi.org/10.1182/blood.V118.21.774.774

Published: 2011

NARROW

A MYC Driven and Metabolite Executed Axis Controls the Subcellular Localization and Activity of TET DNA Hydroxylases and RNA Demethylases in B Cell Lymphomas

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Cyclic-AMP Is an Actionable Novel Regulator of PD-L1 Expression in Untransformed Lymphocytes and Diffuse Large B Cell Lymphomas

Heightened DNA Damage Response and p53 Activation In MiR-155 Null Cells Are Context Specific and Aid Dependent

Microrna-155 Controls The RB/E2F Axis In Normal and Malignant B Cells Via The Non-Canonical TGFβ1-SMAD5 Signaling Module

Targeting of TNFAIP3 (A20) Links MiR-125a and MiR-125b to Constitutive Activation of the NF-KB Pathway and Lymphomagenesis

Email alerts

ASH Publications

American Society of Hematology

A MYC Driven and Metabolite Executed Axis Controls the Subcellular Localization and Activity of TET DNA Hydroxylases and RNA Demethylases in B Cell Lymphomas

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Cyclic-AMP Is an Actionable Novel Regulator of PD-L1 Expression in Untransformed Lymphocytes and Diffuse Large B Cell Lymphomas

Heightened DNA Damage Response and p53 Activation In MiR-155 Null Cells Are Context Specific and Aid Dependent

Microrna-155 Controls The RB/E2F Axis In Normal and Malignant B Cells Via The Non-Canonical TGFβ1-SMAD5 Signaling Module

Targeting of TNFAIP3 (A20) Links MiR-125a and MiR-125b to Constitutive Activation of the NF-KB Pathway and Lymphomagenesis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only